Amphastar Pharmaceuticals, Inc. (AMPH) scores 78 out of 100 on boothcheck's 11-model valuation framework. Verdict: Buy The estimated fair value is $37.12, representing a 93% margin of safety. Quantitative score: 86/100. Qualitative score: 50/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.